Medtech tenders in Latvia.

The market looks large because a small number of awards pull the average up to EUR 281K, while the median sits at EUR 45K. That gap matters. It tells you this is not a uniform field of equal opportunities, but a market with occasional high value packages sitting on top of a much wider base of ordinary buys.

Read it that way and the strategy changes. You are not hunting one giant opportunity. You are deciding which size of deal you can price, service, and defend profitably.

That is the right lens for medical devices. Demand is spread across recurring institutional buyers, not captured by a single centre of gravity. Hospitals, universities, and state linked organisations buy on their own rhythm, and those rhythms repeat.

The strongest suppliers do not just show up once. They map where the same buyer returns to the same category and build around that pattern. That is why the market rewards fit over volume.

If your range matches a repeat need, you can create a durable position. If not, even a large notice may be a dead end. The conclusion is simple.

Follow repeat behaviour, not headline size. The supplier base is open, but it is not loose. 85% of winners took only one contract, which tells you newcomers can still break in.

At the same time, value is concentrated at the top, so the best results go to firms that know exactly which tenders justify effort and which do not. This is where smaller, sharper bids often beat broad scattershot pursuit. The market is competitive, yet still accessible for a supplier with a clear fit and discipline.

The lesson is to enter where repetition, margin, and capability meet.